Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-06-11

Clinical Trial Update: Intravenous Lacosamide Compared With Fosphenytoin in the Treatment of Patients With Frequent Nonconvulsive Seizures [Phase 2]

View source ↗

Summary

Phase 2 trial comparing intravenous lacosamide to fosphenytoin for control of frequent nonconvulsive seizures; results were posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CEREBYX (FOSPHENYTOIN SODIUM)
  • Vimpat (lacosamide)

Snippet

Sponsor: Aatif Husain | Conditions: Nonconvulsive Seizures | Phase 2 | Status: COMPLETED | Results posted: 2018-06-11